BAWEI
837023
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Tongling Jieya Biologic Technology
301108
5
XI'AN WONDER
836419
CN Stock MarketDetailed Quotes
002757 Nanxing Machinery
- 20.03
- -1.31-6.14%
Trading May 15 13:07 CST
5.92BMarket Cap-27.44P/E (TTM)
20.80High19.92Low205.10KlotVolume20.80Open21.34Pre Close414.58MTurnover7.27%Turnover RatioLossP/E (Static)295.46MShares27.5852wk High2.89P/B5.65BFloat Cap10.5852wk Low23.47Limit Up282.05MShs Float28.69Historical High19.21Limit Down4.12%Amplitude4.85Historical Low0.50Dividend TTM20.21Avg Price124.18KlotAsk2.50%Div YieldTTM100Lot Size73.35KlotBid
Nanxing Machinery Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -11.38%845.25M | -8.18%3.33B | -3.91%2.58B | -1.90%1.8B | 1.46%953.8M | 22.58%3.63B | 27.56%2.68B | 30.11%1.83B | 37.28%940.07M | 6.61%2.96B |
| Operating revenue | -11.38%845.25M | -8.18%3.33B | -3.91%2.58B | -1.90%1.8B | 1.46%953.8M | 22.58%3.63B | 27.56%2.68B | 30.11%1.83B | 37.28%940.07M | 6.61%2.96B |
| Other operating revenue | ---- | 9.75%13.79M | ---- | 39.10%8.64M | ---- | -6.71%12.56M | ---- | -26.76%6.21M | ---- | -5.05%13.47M |
| Total operating cost | -6.78%794.84M | -6.65%3.08B | -3.09%2.35B | -2.57%1.62B | 0.18%852.65M | 25.08%3.3B | 29.57%2.42B | 34.23%1.66B | 45.30%851.09M | 7.14%2.64B |
| Operating cost | -6.41%709.42M | -7.73%2.7B | -3.92%2.06B | -4.18%1.43B | -1.49%758M | 27.13%2.93B | 32.16%2.15B | 38.05%1.49B | 50.65%769.47M | 8.28%2.3B |
| Operating tax surcharges | -18.00%3.11M | 5.60%16.67M | 8.04%11.85M | 8.22%8.34M | 38.94%3.79M | 28.00%15.79M | 33.57%10.97M | 24.28%7.7M | 23.46%2.73M | -0.98%12.33M |
| Operating expense | 8.95%14.97M | 2.66%59.02M | 1.95%45.95M | 3.74%30.54M | 3.87%13.74M | 15.12%57.48M | 15.09%45.07M | 32.75%29.44M | 29.65%13.23M | -0.46%49.94M |
| Administration expense | 9.91%33.33M | 1.11%141.75M | -9.04%98.73M | -3.28%63.01M | -1.90%30.32M | 3.74%140.19M | 11.48%108.54M | 7.01%65.15M | 12.66%30.91M | 0.22%135.13M |
| Financial expense | 11.77%7.21M | 7.23%27.14M | -0.19%18.8M | 5.30%13.07M | 2.87%6.45M | 10.25%25.31M | 14.28%18.83M | 17.18%12.41M | 11.84%6.27M | 53.79%22.96M |
| -Interest expense (Financial expense) | 9.34%5.99M | 3.56%30.71M | -6.76%15.97M | 2.07%14.84M | 1.81%5.48M | 8.80%29.66M | 4.78%17.13M | 46.45%14.54M | 1.27%5.38M | 53.76%27.26M |
| -Interest Income (Financial expense) | 45.19%-522.65K | 18.07%-3.78M | 18.56%-2.88M | 16.90%-1.92M | -10.22%-953.62K | -8.96%-4.61M | -6.37%-3.53M | -20.68%-2.31M | 33.35%-865.22K | -36.02%-4.23M |
| Research and development | -33.55%26.8M | 0.33%138.58M | 18.58%110.93M | 34.49%75.25M | 41.62%40.33M | 16.32%138.12M | 10.10%93.55M | -3.49%55.96M | -3.53%28.48M | -6.27%118.74M |
| Credit Impairment Loss | 89.22%-925.22K | -351.61%-9.64M | -185.51%-4.07M | -418.73%-3.71M | -209.14%-8.58M | 84.03%-2.14M | 83.06%-1.43M | 127.50%1.17M | 75.76%-2.78M | 16.31%-13.37M |
| Asset Impairment Loss | ---- | -171.20%-385.23M | ---- | --0 | ---- | -2,381.79%-142.05M | ---- | --0 | --0 | -217.01%-5.72M |
| Other net revenue | 219.79%3.62M | -258.57%-369.09M | -37.17%14.8M | -51.42%9.77M | -140.98%-3.02M | -648.08%-102.93M | 62.66%23.56M | 155.14%20.11M | 201.11%7.37M | -16.56%18.78M |
| Fair value change income | ---- | -115.19%-57.22K | ---- | ---- | ---376.67K | 112.55%376.67K | ---- | ---- | ---- | ---3M |
| Invest income | -33.69%1.66M | 18.03%7.98M | 9.81%6.26M | 11.84%4.28M | 60.68%2.5M | 112.54%6.76M | 177.96%5.7M | 126.16%3.83M | 126.56%1.56M | 31.41%3.18M |
| -Including: Investment income associates | ---- | 63.58%-131.32K | ---- | ---- | ---- | -193.12%-360.59K | ---- | ---- | ---- | 193.83%387.24K |
| Asset deal income | -12,505.90%-31.43K | -37.10%513.23K | -94.69%47.49K | -98.66%13.83K | -3,877.42%-249.31 | 1,142.26%815.89K | 5,192.43%893.55K | 12,524.87%1.03M | -99.64%6.6 | 116.56%65.68K |
| Other revenue | -15.27%2.91M | -47.87%17.36M | -31.67%12.57M | -34.76%9.19M | -59.95%3.44M | -11.51%33.3M | -11.85%18.39M | 34.96%14.09M | 146.86%8.59M | 19.20%37.63M |
| Operating profit | -44.94%54.03M | -153.39%-119.48M | -13.73%242.65M | -1.36%190.8M | 1.86%98.13M | -34.04%223.8M | 14.33%281.27M | 7.38%193.43M | 5.02%96.34M | 1.13%339.28M |
| Add:Non operating Income | ---- | -96.51%37.06K | -77.31%5.48K | -92.95%1.4K | -94.62%495.3 | 4,363.15%1.06M | 111.10%24.14K | 217.22%19.88K | 340,730.00%9.2K | -92.53%23.77K |
| Less:Non operating expense | 393.12%631.42K | 456.69%7.33M | 154.82%1.74M | 129.79%759.43K | 789.76%128.05K | -50.20%1.32M | -70.49%681.55K | -85.37%330.49K | -3.40%14.39K | 200.52%2.64M |
| Total profit | -45.51%53.4M | -156.71%-126.76M | -14.14%240.92M | -1.59%190.04M | 1.73%98M | -33.60%223.54M | 15.14%280.61M | 8.56%193.12M | 5.03%96.34M | 0.52%336.66M |
| Less:Income tax cost | -23.30%9.53M | 14.06%48.65M | -20.33%31.1M | -17.39%22.51M | -0.33%12.42M | 20.68%42.65M | 6.07%39.04M | -0.19%27.25M | 1.63%12.47M | -6.29%35.34M |
| Net profit | -48.74%43.87M | -196.97%-175.41M | -13.14%209.82M | 1.00%167.53M | 2.04%85.58M | -39.97%180.89M | 16.75%241.57M | 10.15%165.87M | 5.55%83.87M | 1.38%301.32M |
| Net profit from continuing operation | -48.74%43.87M | -196.97%-175.41M | -13.14%209.82M | 1.00%167.53M | 2.04%85.58M | -39.97%180.89M | 16.75%241.57M | 10.15%165.87M | 5.55%83.87M | 1.38%301.32M |
| Less:Minority Profit | -62.03%674.73K | -103.45%-262.56K | -56.58%2.6M | -49.90%2.16M | -14.70%1.78M | -15.09%7.62M | 0.82%6M | 15.39%4.31M | 6.68%2.08M | 53.39%8.97M |
| Net profit of parent company owners | -48.46%43.2M | -201.08%-175.15M | -12.04%207.21M | 2.36%165.37M | 2.46%83.8M | -40.73%173.27M | 17.22%235.57M | 10.01%161.56M | 5.52%81.79M | 0.33%292.34M |
| Earning per share | ||||||||||
| Basic earning per share | -48.45%0.1462 | -201.09%-0.5928 | -12.04%0.7013 | 2.36%0.5597 | 2.46%0.2836 | -40.74%0.5864 | 17.22%0.7973 | 10.02%0.5468 | 5.53%0.2768 | 0.35%0.9895 |
| Diluted earning per share | -48.45%0.1462 | -201.09%-0.5928 | -12.04%0.7013 | 2.36%0.5597 | 2.46%0.2836 | -40.74%0.5864 | 17.22%0.7973 | 10.02%0.5468 | 5.53%0.2768 | 0.35%0.9895 |
| Other composite income | 0.00%-201.75K | 0.00%-201.75K | 0.00%-201.75K | |||||||
| Other composite income of parent company owners | ---- | 0.00%-201.75K | ---- | ---- | ---- | 0.00%-201.75K | ---- | ---- | ---- | 0.00%-201.75K |
| Total composite income | -48.74%43.87M | -197.19%-175.61M | -13.14%209.82M | 1.00%167.53M | 2.04%85.58M | -39.99%180.69M | 16.75%241.57M | 10.15%165.87M | 5.55%83.87M | 1.38%301.11M |
| Total composite income of parent company owners | -48.46%43.2M | -201.32%-175.35M | -12.04%207.21M | 2.36%165.37M | 2.46%83.8M | -40.76%173.07M | 17.22%235.57M | 10.01%161.56M | 5.52%81.79M | 0.34%292.14M |
| Total composite income of minority owners | -62.03%674.73K | -103.45%-262.56K | -56.58%2.6M | -49.90%2.16M | -14.70%1.78M | -15.09%7.62M | 0.82%6M | 15.39%4.31M | 6.68%2.08M | 53.39%8.97M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.